Skip to main content

CervoMed Inc.

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

CRVO$1.43+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. EXHIBITS

Exhibit No.DescriptionMethod of Filing
10.1Form of Stock Option Award Agreement under the CervoMed Inc. 2025 Equity Incentive PlanFiled herewith
31.1Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)Filed herewith.
31.2Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)Filed herewith.
32.1Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b)Furnished herewith.
32.2Certification of Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b)Furnished herewith.
101.INS*Inline XBRL Instance DocumentFiled herewith.
101.SCH*Inline XBRL Taxonomy Extension Schema DocumentFiled herewith.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase DocumentFiled herewith.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase DocumentFiled herewith.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled herewith.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)Filed herewith.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.